Literature DB >> 2528433

Functional analysis of lymphocytes subpopulations in experimental cocaine abuse. I. Dose-dependent activation of lymphocyte subsets.

O Bagasra1, L Forman.   

Abstract

The potential role of substance abuse, especially cocaine and alcohol as co-factor in HIV infection and in the development and expression of AIDS has been suggested, but the possible biological role of substance abuse in the development of AIDS is not known. In order to better understand immune system function in chronic cocaine abuse, we have assessed primary B cell responses to helper T-cell independent (TI) and dependent (TD) antigens in inbred Fisher male rats injected with 1.25-5 mg cocaine/kg body weight for 10 days. The ability of cocaine-exposed animals to mount primary in vivo splenic plaque-forming cell (PFC) and serum antibody responses to the TI antigen, pneumococcal polysaccharide type III (SIII), was elevated several-fold when compared with controls. The degree of elevation of humoral antibody responses seemed to be directly related to the dose of cocaine. Primary in vivo B cell responses to the TD antigen, sheep red blood cells (SRBC), was elevated at lower concentrations of cocaine (1.25-2.5 mg/kg) and was found to be significantly suppressed after chronic exposure to the higher concentration (5.0 mg/kg). The elevated primary splenic immunostimulation to TI (SIII) may be attributed to a combination of loss of T suppressor cell control and direct B cell stimulation. Elevated immune responses to SRBC at lower concentrations were attributed to stimulation of T helper cells as well as loss of T suppressor cells. Immunosuppression to SRBC observed in response to 5.0 mg/kg of cocaine was most probably due to loss of T helper cell subset functions. These findings were further tested by in vitro methods, where splenic lymphocytes from cocaine-exposed animals were examined for their ability to respond to concanavalin A (Con A) in terms of the induction of antigen non-specific suppressor T cells. The addition of Con A-stimulated splenic lymphocytes from cocaine-treated animals did not inhibit the primary antibody responses of SRBC as compared with saline-treated controls, indicating that suppressor T cells malfunction after cocaine exposure. Lymphocyte subpopulation analysis using fluorescein-labelled monoclonal antibodies showed a significant increase in the B cell populations at doses of 1.25-5 mg/kg. A reciprocal change in T cell populations also took place. No significant numerical change in macrophage (NSE+) and T cell subset, T helper and T suppressor was noticed, suggesting that cocaine probably directly effects mature T cell subset functions but does not affect their differentiation.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2528433      PMCID: PMC1541992     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor.

Authors:  R Sapolsky; C Rivier; G Yamamoto; P Plotsky; W Vale
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

2.  Cocaine use and HIV infection in intravenous drug users in San Francisco.

Authors:  R E Chaisson; P Bacchetti; D Osmond; B Brodie; M A Sande; A R Moss
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

3.  Cocaine influences beta-endorphin levels and release.

Authors:  L J Forman; S Estilow
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

4.  The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report.

Authors:  N Levy; J R Carlson; S Hinrichs; N Lerche; M Schenker; M B Gardner
Journal:  N Engl J Med       Date:  1986-02-13       Impact factor: 91.245

5.  Lymphocyte function in experimental African trypanosomiasis. I. B cell responses to helper T cell-independent and -dependent antigens.

Authors:  J M Mansfield; O Bagasra
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

6.  rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1.

Authors:  R Patarca; G J Freeman; J Schwartz; R P Singh; Q T Kong; E Murphy; Y Anderson; F Y Sheng; P Singh; K A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  Lymphocyte function in experimental endemic syphilis of Syrian hamsters.

Authors:  O Bagasra; H Kushner; S Hashemi
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

8.  Immune response of mice exposed to cis-diamminedichloroplatinum.

Authors:  O Bagasra; L Currao; L R DeSouza; J W Oosterhuis; I Damjanov
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

9.  Activated T cells in addition to LAV/HTLV-III infection: a necessary precondition for development of AIDS.

Authors:  D Fuchs; A Hausen; E Hoefler; D Schönitzer; E R Werner; M P Dierich; P Hengster; G Reibnegger; T Schulz; H Wachter
Journal:  Cancer Detect Prev Suppl       Date:  1987

10.  Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cells.

Authors:  P J Baker; N D Reed; P W Stashak; D F Amsbaugh; B Prescott
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 2.  Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems.

Authors:  Christina C Marasco; Cody R Goodwin; Danny G Winder; Nicole L Schramm-Sapyta; John A McLean; John P Wikswo
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-05

3.  Effect of Ocimum sanctum, ascorbic acid, and verapamil on macrophage function and oxidative stress in mice exposed to cocaine.

Authors:  S K Bhattacharya; N Rathi; P Mahajan; A K Tripathi; K R Paudel; G P Rauniar; B P Das
Journal:  Indian J Pharmacol       Date:  2009-06       Impact factor: 1.200

4.  Combined effect of fluconazole and thymosin alpha 1 on systemic candidiasis in mice immunosuppressed by morphine treatments.

Authors:  P di Francesco; R Gaziano; I A Casalinuovo; L Belogi; A T Palamara; C Favalli; E Garaci
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

5.  Adenosine-deaminase-associated immunodeficiency. I. Differential sensitivities of lymphocyte subpopulations exposed to 2-deoxycoformycin in vivo.

Authors:  O Bagasra; A Howeedy; R J Pomerantz
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

6.  Proteomic analyses of the effects of drugs of abuse on monocyte-derived mature dendritic cells.

Authors:  Jessica L Reynolds; Supriya D Mahajan; Ravikunar Aalinkeel; B Nair; Donald E Sykes; Stanley A Schwartz
Journal:  Immunol Invest       Date:  2009       Impact factor: 3.657

7.  Real-time cellular exometabolome analysis with a microfluidic-mass spectrometry platform.

Authors:  Christina C Marasco; Jeffrey R Enders; Kevin T Seale; John A McLean; John P Wikswo
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

8.  Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users.

Authors:  Michael S Piepenbrink; Memorie Samuel; Bo Zheng; Brittany Carter; Christopher Fucile; Catherine Bunce; Michelle Kiebala; Atif A Khan; Juilee Thakar; Sanjay B Maggirwar; Diane Morse; Alexander F Rosenberg; Norman J Haughey; William Valenti; Michael C Keefer; James J Kobie
Journal:  PLoS One       Date:  2016-07-05       Impact factor: 3.240

9.  Psychoimmunology and infection.

Authors:  Thomas W Klein
Journal:  Clin Microbiol Newsl       Date:  2002-11-15

10.  Elevated Neutrophil to Lymphocyte Ratio in Older Adults with Cocaine Use Disorder as a Marker of Chronic Inflammation.

Authors:  Heather E Soder; Amber M Berumen; Kira E Gomez; Charles E Green; Robert Suchting; Margaret C Wardle; Jessica Vincent; Antonio L Teixeira; Joy M Schmitz; Scott D Lane
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-02-29       Impact factor: 2.582

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.